BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma Research

ATLATL And Daiichi Sankyo Partner To Advance APAC Driven Biopharma Innovation

ATLATL Innovation Center (hereinafter referred to as "ATLATL"), a global innovation platform for life science research and development, announced an agreem...

April 09, 2026 | News

Perceptive Discovery Expands In Vitro Capabilities To Accelerate Oncology Drug Development

Perceptive Discovery, a leading scientific partner to the global biopharmaceutical industry, announced a major expansion of its in vitro laboratory capabil...

April 07, 2026 | News

IDEAYA Biosciences Advances IDE574 Into Phase 1 As First Patient Enrolled For KAT6 And KAT7 Dual Inhibitor

Potential first-in-class and selective equipotent dual inhibitor of KAT6/7 with single-digit to low teens nano-molar cellular potency...

April 07, 2026 | News

Neurocrine Biosciences To Acquire Soleno Therapeutics For $2.9 Billion To Strengthen Rare Disease Portfolio

VYKAT™ XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and...

April 07, 2026 | News

Gan And Lee Pharmaceuticals Reports Phase 3 Success For Once Weekly Insulin GZR4

Gan & Lee Pharmaceuticals announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating investigative once-weekly insulin GZR4 In...

April 02, 2026 | News

Hengrui Pharma And Braveheart Bio Report Strong Phase 2 Results For HRS 1893 In Obstructive Hypertrophic Cardiomyopathy

Results of dose-ranging study suggest potential for best-in-class clinical profile across efficacy, safety and ease of use, including s...

April 01, 2026 | News

Matricelf And CiRA Foundation Partner To Advance Scalable iPSC Based Neural Tissue Manufacturing

Matricelf Ltd. (TASE: MTLF), a biotechnology company developing a novel autologous engineered neural tissue therapy for patients with spinal cord injury, a...

March 31, 2026 | News

WuXi XDC Reports Strong 2025 Growth Driven By Bioconjugate Leadership And Expanding Global Footprint

Revenue increased by 46.7% YoY to RMB 5,944 million Gross profit surged by 72.5% YoY to RMB 2,139 million, with its margin of 3...

March 25, 2026 | Company results

Monash University And ClinChoice Partner To Accelerate Early Phase Clinical Trials

Monash University and ClinChoice Inc, a leading global clinical Contract Research Organization (CRO) focused on innovative therapeutics, announced a strate...

March 23, 2026 | News

MGI Tech Singapore And NUS Partner To Establish Advanced Multi Omics Laboratory For Pharmaceutical Innovation

MGI Tech Singapore Pte. Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and the Departm...

March 23, 2026 | News

DNA Script Expands Global Reach Of SYNTAX Platform Through Strategic Distribution Partnerships

DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, announced it has signed distribution ag...

March 19, 2026 | News

Alphamab Oncology IND For Dual Payload Bispecific ADC JSKN021 Accepted By China NMPA

Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN021, an independently developed innovative du...

March 16, 2026 | News

BrainXell Launches Human iPSC Derived Sensory Neurons Platform To Advance Pain And Ion Channel Research

BrainXell announced the launch of its human induced pluripotent stem cell (iPSC)-derived sensory neurons, a scalable human cellular platform engineer...

March 06, 2026 | News

Akeso Reports Durable Long Term Survival Benefit Of Cadonilimab In Advanced Cervical Cancer

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the latest long-term survival analysis data from the China pivotal registrational Phase II ...

March 06, 2026 | Report

Stay Connected